ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2020

Apr 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2020-04-20

Reporting Person: Bjork Elisabeth (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-20	Stock Option (Right to Buy)	$17.5	A	40000	Acquired	2030-04-20	Common Stock (40000)	Direct

Footnotes

F1: This option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, 1/3 of which shall vest on the first anniversary of the date of this grant and the remaining 2/3 of which shall vest in equal monthly installments over the subsequent two years.